Antiangiogenic agents

Final results from the randomised phase III METEOR study have confirmed the superiority of Cabozantinib over Everolimus in patients with...


Antiangiogenic agents Sunitinib ( Sutent ) and Pazopanib ( Votrient ) are SOC ( standard of care ) for metastatic...


Denosumab ( Prolia ) is a human monoclonal antibody ( IgG2 ) that targets and binds with high affinity and...


Daiichi Sankyo has announced the results of a prespecified subgroup analysis of 771 cancer patients enrolled in the phase 3...